重磅-话题@MedSci

#重磅#

1136篇内容 | 2947人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1549837, encodeId=34ec154983e84, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！欧唐静®（恩格列净片）新适应症在华获批，用于治疗射血分数降低的成人心力衰竭, objectType=article, longId=729048, objectId=5b2ee29048b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b2ee29048b5, replyNumber=0, likeNumber=46, createdTime=2022-06-11, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b2ee29048b5, moduleTitle=重磅！欧唐静®（恩格列净片）新适应症在华获批，用于治疗射血分数降低的成人心力衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b2ee29048b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549838, encodeId=1e5c154983866, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO2022 | TROPiCS-02临床重磅发布：戈沙妥珠单抗使HR+/HER2-MBC进展或死亡降低34%！, objectType=article, longId=728853, objectId=14b5e2885349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14b5e2885349, replyNumber=0, likeNumber=55, createdTime=2022-06-09, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14b5e2885349, moduleTitle=ASCO2022 | TROPiCS-02临床重磅发布：戈沙妥珠单抗使HR+/HER2-MBC进展或死亡降低34%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14b5e2885349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549836, encodeId=8beb1549836cb, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！2022年度中国高校科技进步贡献100强出炉！, objectType=article, longId=728845, objectId=b551e288453d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b551e288453d, replyNumber=0, likeNumber=42, createdTime=2022-06-09, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b551e288453d, moduleTitle=重磅！2022年度中国高校科技进步贡献100强出炉！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b551e288453d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549835, encodeId=bcc31549835d1, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO 2022：神经肿瘤领域重磅研究合集, objectType=article, longId=728829, objectId=17b8e28829df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17b8e28829df, replyNumber=0, likeNumber=40, createdTime=2022-06-09, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17b8e28829df, moduleTitle=ASCO 2022：神经肿瘤领域重磅研究合集, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17b8e28829df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549834, encodeId=3be615498344d, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO 2022：神经肿瘤重磅研究荟萃, objectType=article, longId=728705, objectId=b0ece2870549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0ece2870549, replyNumber=0, likeNumber=50, createdTime=2022-06-07, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0ece2870549, moduleTitle=ASCO 2022：神经肿瘤重磅研究荟萃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0ece2870549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549833, encodeId=d60e1549833cc, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=聚焦2022 ASCO肺癌研究，重磅发现荟萃, objectType=article, longId=728704, objectId=9987e2870456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9987e2870456, replyNumber=0, likeNumber=47, createdTime=2022-06-07, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9987e2870456, moduleTitle=聚焦2022 ASCO肺癌研究，重磅发现荟萃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9987e2870456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549832, encodeId=f9d1154983202, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO 2022 | 胃肠道肿瘤领域重磅研究进展, objectType=article, longId=728664, objectId=0b05e28664b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b05e28664b9, replyNumber=0, likeNumber=50, createdTime=2022-06-07, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b05e28664b9, moduleTitle=ASCO 2022 | 胃肠道肿瘤领域重磅研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b05e28664b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549831, encodeId=fe60154983162, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=聚焦 2022 ASCO 肺癌研究，重磅发现荟萃, objectType=article, longId=728631, objectId=8495e2863194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8495e2863194, replyNumber=0, likeNumber=39, createdTime=2022-06-06, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8495e2863194, moduleTitle=聚焦 2022 ASCO 肺癌研究，重磅发现荟萃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8495e2863194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549830, encodeId=9686154983023, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=免费领取ASCO重磅资料, objectType=article, longId=728587, objectId=58d1e28587ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58d1e28587ae, replyNumber=0, likeNumber=0, createdTime=2022-06-05, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58d1e28587ae, moduleTitle=免费领取ASCO重磅资料, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58d1e28587ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549828, encodeId=ce7c15498286e, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=《良性前列腺增生诊疗及健康管理指南》重磅发布，夏荔芪胶囊荣获推荐, objectType=article, longId=728463, objectId=b65de28463c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b65de28463c4, replyNumber=0, likeNumber=36, createdTime=2022-06-03, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b65de28463c4, moduleTitle=《良性前列腺增生诊疗及健康管理指南》重磅发布，夏荔芪胶囊荣获推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b65de28463c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549829, encodeId=485a1549829c8, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO指南重磅更新！对于HER2阳性晚期乳腺癌，最佳治疗到底是什么？最新最全循证依据也都在这了！, objectType=article, longId=728444, objectId=eacae28444f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eacae28444f5, replyNumber=0, likeNumber=47, createdTime=2022-06-03, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eacae28444f5, moduleTitle=ASCO指南重磅更新！对于HER2阳性晚期乳腺癌，最佳治疗到底是什么？最新最全循证依据也都在这了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eacae28444f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549826, encodeId=1c4e154982699, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！BNT162b2 mRNA新冠疫苗复必泰2期临床试验结果发布, objectType=article, longId=728324, objectId=3580e2832448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3580e2832448, replyNumber=0, likeNumber=56, createdTime=2022-06-02, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3580e2832448, moduleTitle=重磅！BNT162b2 mRNA新冠疫苗复必泰2期临床试验结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3580e2832448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549827, encodeId=b7cc154982e49, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO重磅：晚期胃癌最佳生物标志物的开放标签、多中心、随机、生物标志物整合试验, objectType=article, longId=728265, objectId=f113e2826548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f113e2826548, replyNumber=0, likeNumber=42, createdTime=2022-06-01, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f113e2826548, moduleTitle=ASCO重磅：晚期胃癌最佳生物标志物的开放标签、多中心、随机、生物标志物整合试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f113e2826548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549825, encodeId=592b154982516, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Science：重磅！小胶质细胞吞噬神经周围网络介导疼痛行为, objectType=article, longId=728183, objectId=baebe2818367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=baebe2818367, replyNumber=0, likeNumber=42, createdTime=2022-05-31, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=baebe2818367, moduleTitle=Science：重磅！小胶质细胞吞噬神经周围网络介导疼痛行为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=baebe2818367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549824, encodeId=0989154982421, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Nature重磅：通用型癌症疫苗来了，同时激活T细胞和NK细胞，加速消灭癌细胞, objectType=article, longId=728090, objectId=b6dae2809055, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6dae2809055, replyNumber=0, likeNumber=0, createdTime=2022-05-30, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6dae2809055, moduleTitle=Nature重磅：通用型癌症疫苗来了，同时激活T细胞和NK细胞，加速消灭癌细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6dae2809055)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549823, encodeId=0e5515498234b, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！《“十四五”国民健康规划》发布, objectType=article, longId=727444, objectId=2b4de27444fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b4de27444fd, replyNumber=0, likeNumber=46, createdTime=2022-05-22, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b4de27444fd, moduleTitle=重磅！《“十四五”国民健康规划》发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b4de27444fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549821, encodeId=7c0a1549821d8, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！罗蒙、虞涛任上海市卫生健康委副主任, objectType=article, longId=727376, objectId=769de2737626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=769de2737626, replyNumber=0, likeNumber=38, createdTime=2022-05-21, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=769de2737626, moduleTitle=重磅！罗蒙、虞涛任上海市卫生健康委副主任, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=769de2737626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549820, encodeId=a3661549820d7, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Nature：破解卵子起源的糖尿病遗传之谜！黄荷凤院士/徐国良院士团队重磅研究发布！, objectType=article, longId=727320, objectId=7111e27320e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7111e27320e5, replyNumber=0, likeNumber=48, createdTime=2022-05-20, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7111e27320e5, moduleTitle=Nature：破解卵子起源的糖尿病遗传之谜！黄荷凤院士/徐国良院士团队重磅研究发布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7111e27320e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549822, encodeId=be61154982201, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=默克创新佳-2022临床科研系列培训课重磅来袭~, objectType=article, longId=727253, objectId=dcd6e27253bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcd6e27253bd, replyNumber=0, likeNumber=13, createdTime=2022-05-20, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcd6e27253bd, moduleTitle=默克创新佳-2022临床科研系列培训课重磅来袭~, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcd6e27253bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549819, encodeId=d8c3154981908, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！北医三院乔杰院士团队在《柳叶刀全球健康》发表最新研究成果, objectType=article, longId=726690, objectId=d65ae2669045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d65ae2669045, replyNumber=0, likeNumber=34, createdTime=2022-05-13, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d65ae2669045, moduleTitle=重磅！北医三院乔杰院士团队在《柳叶刀全球健康》发表最新研究成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d65ae2669045)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重磅

2020-05-29

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！欧唐静®（恩格列净片）新适应症在华获批，用于治疗射血分数降低的成人心力衰竭

2022-06-11

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO2022 | TROPiCS-02临床重磅发布：戈沙妥珠单抗使HR+/HER2-MBC进展或死亡降低34%！

2022-06-09

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！2022年度中国高校科技进步贡献100强出炉！

2022-06-09

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO 2022：神经肿瘤领域重磅研究合集

2022-06-09

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO 2022：神经肿瘤重磅研究荟萃

2022-06-07

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

聚焦2022 ASCO肺癌研究，重磅发现荟萃

2022-06-07

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO 2022 | 胃肠道肿瘤领域重磅研究进展

2022-06-07

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

聚焦 2022 ASCO 肺癌研究，重磅发现荟萃

2022-06-06

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

免费领取ASCO重磅资料

2022-06-05

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

《良性前列腺增生诊疗及健康管理指南》重磅发布，夏荔芪胶囊荣获推荐

2022-06-03

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO指南重磅更新！对于HER2阳性晚期乳腺癌，最佳治疗到底是什么？最新最全循证依据也都在这了！

2022-06-03

一叶知秋 (审核中...)

前往app查看评论内容

#重磅#

重磅！BNT162b2 mRNA新冠疫苗复必泰2期临床试验结果发布

2022-06-02

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO重磅：晚期胃癌最佳生物标志物的开放标签、多中心、随机、生物标志物整合试验

2022-06-01

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Science：重磅！小胶质细胞吞噬神经周围网络介导疼痛行为

2022-05-31

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Nature重磅：通用型癌症疫苗来了，同时激活T细胞和NK细胞，加速消灭癌细胞

2022-05-30

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！《“十四五”国民健康规划》发布

2022-05-22

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！罗蒙、虞涛任上海市卫生健康委副主任

2022-05-21

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Nature：破解卵子起源的糖尿病遗传之谜！黄荷凤院士/徐国良院士团队重磅研究发布！

2022-05-20

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

默克创新佳-2022临床科研系列培训课重磅来袭~

2022-05-20

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！北医三院乔杰院士团队在《柳叶刀全球健康》发表最新研究成果

2022-05-13

科室
- - 订阅+
  - 更多科室
工具
服务